Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia - Concepedia

Concepedia

Publication | Closed Access

Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia

94

Citations

22

References

2018

Year

Jonas Paludo, Jithma P. Abeykoon, Amanda Shreders, Stephen M. Ansell, Shaji Kumar, Sikander Ailawadhi, Rebecca L. King, Amber B. Koehler, Craig B. Reeder, Francis K. Buadi,

Annals of Hematology

MedicineHematologyPathologyWaldenström MacroglobulinemiaPharmacologyVersus Dexamethasone

References

	Year	Citations

Page 1